首页> 美国卫生研究院文献>Regenerative Biomaterials >Degradation characteristics cell viability and host tissue responses of PDLLA-based scaffold with PRGD and β-TCP nanoparticles incorporation
【2h】

Degradation characteristics cell viability and host tissue responses of PDLLA-based scaffold with PRGD and β-TCP nanoparticles incorporation

机译:结合PRGD和β-TCP纳米粒子的PDLLA基支架的降解特性细胞活力和宿主组织反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study is aimed to evaluate the degradation characteristics, cell viability and host tissue responses of PDLLA/PRGD/β-TCP (PRT) composite nerve scaffold, which was fabricated by poly(d, l-lactic acid) (PDLLA), RGD peptide(Gly-Arg-Gly-Asp-Tyr, GRGDY, abbreviated as RGD) modified poly-{(lactic acid)-co-[(glycolic acid)-alt-(l-lysine)]}(PRGD) and β-tricalcium phosphate (β-TCP). The scaffolds’ in vitro degradation behaviors were investigated in detail by analysing changes in weight loss, pH and morphology. Then, the 3-(4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2 -H-tetrazolium bromide (MTT) assay and cell live/dead assay were carried out to assess their cell viability. Moreover, in vivo degradation patterns and host inflammation responses were monitored by subcutaneous implantation of PRT scaffold in rats. Our data showed that, among the tested scaffolds, the PRT scaffold had the best buffering capacity (pH = 6.1–6.3) and fastest degradation rate (12.4%, 8 weeks) during in vitro study, which was contributed by the incorporation of β-TCP nanoparticles. After in vitro and in vivo degradation, the high porosity structure of PRT could be observed using scanning electron microscopy. Meanwhile, the PRT scaffold could significantly promote cell survival. In the PRT scaffold implantation region, less inflammatory cells (especially for neutrophil and lymphocyte) could be detected. These results indicated that the PRT composite scaffold had a good biodegradable property; it could improve cells survival and reduced the adverse host tissue inflammation responses.
机译:这项研究旨在评估PDLLA / PRGD /β-TCP(PRT)复合神经支架的降解特性,细胞活力和宿主组织反应,该支架由聚(d,l-乳酸)(PDLLA),RGD肽制成(Gly-Arg-Gly-Asp-Tyr,GRGDY,缩写为RGD)改性的聚-{(乳酸)-co-[[乙醇酸)-alt-(1-赖氨酸)]}(PRGD)和β-三钙磷酸盐(β-TCP)。通过分析失重,pH和形态的变化,详细研究了支架的体外降解行为。然后,进行3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2-H-溴化四唑(MTT)测定和细胞活/死测定,以评估它们的细胞生存力。此外,通过在大鼠中皮下植入PRT支架来监测体内降解模式和宿主炎症反应。我们的数据显示,在体外研究过程中,PRT支架的缓冲能力最佳(pH = 6.1–6.3),降解速率最快(12.4%,8周),这归因于β- TCP纳米粒子。在体外和体内降解后,可以使用扫描电子显微镜观察到PRT的高孔隙率结构。同时,PRT支架可以显着促进细胞存活。在PRT支架植入区域中,可以检测到较少的炎症细胞(尤其是嗜中性粒细胞和淋巴细胞)。这些结果表明PRT复合支架具有良好的生物降解性能。它可以提高细胞存活率并减少不良的宿主组织炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号